Search Results - "Ruiz, Juan I"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review by Ruiz, Juan I, Lopez-Olivo, Maria A, Geng, Yimin, Suarez-Almazor, Maria E

    “…Immune checkpoint inhibitors (ICIs) can cause inflammatory and immune-related adverse events (irAEs) that might worsen the course of COVID-19. We conducted a…”
    Get full text
    Journal Article
  2. 2

    Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer by Suarez-Almazor, Maria E., Ruiz, Juan I., Lei, Xiudong, Wu, Chi-Fang, Zhao, Hui, Rajan, Suja S., Giordano, Sharon H.

    Published in Clinical rheumatology (01-11-2024)
    “…Introduction Biologic disease-modifying antirheumatic drugs (bDMARD) are often discontinued when a patient with rheumatoid arthritis (RA) is diagnosed with…”
    Get full text
    Journal Article
  3. 3

    Utilization of Biologic Disease‐Modifying Antirheumatic Therapy in Patients With Rheumatoid Arthritis and Recently Diagnosed Breast Cancer by Ruiz, Juan I., Lei, Xiudong, Wu, Chi‐Fang, Zhao, Hui, Giordano, Sharon H., Rajan, Suja S., Suarez‐Almazor, Maria E.

    Published in Arthritis care & research (2010) (01-06-2024)
    “…Objective Biologic disease‐modifying antirheumatic drugs (bDMARDs) are immunosuppressants, and there have been concerns that they might impact tumor immunity…”
    Get full text
    Journal Article
  4. 4

    Survival in patients with rheumatoid arthritis and early breast cancer treated with tumor necrosis factor inhibitors by Ruiz, Juan I., Lei, Xiudong, Chi-Fang, Wu, Giordano, Sharon H., Zhao, Hui, Rajan, Suja S., Lin, Heather, Suarez-Almazor, Maria E.

    Published in Breast cancer (Tokyo, Japan) (01-11-2024)
    “…Background There have been concerns about the use of tumor necrosis factor inhibitors (TNFi) for autoimmune disease in patients with recently diagnosed cancer…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    1239 Major adverse cardiovascular events (MACE) in patients with melanoma receiving immune checkpoint inhibitors by Ruiz, Juan I, Zhao, Bo, Palaskas, Nicolas, Deswal, Anita, Zhao, Hui, McQuade, Jennifer, Suarez-Almazor, Maria E

    Published in Journal for immunotherapy of cancer (01-11-2023)
    “…BackgroundImmune checkpoint inhibitors (ICI) can persistently augment immune and inflammatory pathways. While cardiovascular immune-related adverse events…”
    Get full text
    Journal Article
  8. 8

    Effect of healthcare spending on the relationship between the Human Development Index and maternal and neonatal mortality by Nuhu, Kaamel M, McDaniel, Justin T, Alorbi, Genevieve A, Ruiz, Juan I

    Published in International health (01-01-2018)
    “…Abstract Background Several factors affect morbidity and mortality the world over. Previous research shows mortality rates are higher among individuals of…”
    Get full text
    Journal Article
  9. 9

    Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism by Clavijo, María Manuela, Vicente Reparaz, María de los Angeles, Ruiz, Juan I, Acuña, María Angeles, Casali, Claudia E, Aizpurua, María Florencia, Mahuad, Carolina V, Eciolaza, Sebastian, Ventura, Adriana, Garate, Gonzalo M

    Published in Curēus (Palo Alto, CA) (24-09-2021)
    “…Introduction From the beginning of the current coronavirus disease 2019 (COVID-19) pandemic, there is cumulative evidence suggesting that patients hospitalized…”
    Get full text
    Journal Article
  10. 10

    Colorectal Cancer, Socioeconomic Distribution and Behavior: A Comparative Analysis of Urban and Rural Counties in the USA by Nuhu, Kaamel M, McDaniel, Justin T, Ruiz, Juan I

    “…Background: Colorectal cancer (CRC) ranks second for all cancer related deaths among men and women together and third for either sex when considered…”
    Get full text
    Journal Article